Try our Advanced Search for more refined results

Austrian Court Hands Ranbaxy Lipitor Win

By Marius Meland ( April 25, 2006, 12:00 AM EDT) -- In a boost for Ranbaxy Laboratories Ltd., an Austrian court has upheld an earlier decision invalidating Pfizer Inc.'s patent on Lipitor, enabling the Indian generic drug maker to push forward in its attempt to launch a generic version of the blockbuster cholesterol drug....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Companies

Government Agencies

Patents